English | Español
Jamie Barrand | Feb 13, 2016

Johnson & Johnson shares information about Zika virus
Jamie Barrand | Feb 13, 2016

Enrollment complete for genetic-based biomarker risk assignment algorithm trial
Jamie Barrand | Feb 13, 2016

AbbVie introduces scholarship for students with rheumatological conditions
Jamie Barrand | Feb 13, 2016

'The Lancet' publishes trial results for anti-cancer agent
Jamie Barrand | Feb 13, 2016

University of Michigan, AstraZeneca partner on chronic kidney disease consortium
Jamie Barrand | Feb 13, 2016

Sandoz acquires infliximab inhibitor treatment from Pfizer
Jamie Barrand | Feb 11, 2016

BIO officials oppose funding cuts in president's proposed 2017 budget
Jamie Barrand | Feb 11, 2016

Trial results positive for possible endometriosis therapy

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'